au.\*:("MCFARLAND, Elizabeth J")
Results 1 to 12 of 12
Selection :
Evaluating ELISPOT summary measures with criteria for obtaining reliable estimatesCHAN ZENG; MAWHINNEY, Samantha; BARON, Anna E et al.Journal of immunological methods. 2005, Vol 297, Num 1-2, pp 97-108, issn 0022-1759, 12 p.Article
Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected childrenSTARR, Stuart E; MCFARLAND, Elizabeth J; MURESAN, Petronella et al.AIDS (London). 2003, Vol 17, Num 15, pp 2181-2189, issn 0269-9370, 9 p.Article
Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatmentWILLIAMS, Paige L; ABZUG, Mark J; BORKOWSKY, William et al.AIDS (London). 2013, Vol 27, Num 12, pp 1959-1970, issn 0269-9370, 12 p.Article
Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-Infected womenJOHNSON, Daniel C; MCFARLAND, Elizabeth J; VINCENT, Carol A et al.The Journal of infectious diseases. 2005, Vol 192, Num 12, pp 2129-2133, issn 0022-1899, 5 p.Article
HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothersMCFARLAND, Elizabeth J; JOHNSON, Daniel C; GURUNATHAN, Sanjay et al.AIDS (London). 2006, Vol 20, Num 11, pp 1481-1489, issn 0269-9370, 9 p.Article
Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort StudyJACOBSON, Denise L; PATEL, Kunjal; FIELDING, Roger A et al.The American journal of clinical nutrition. 2011, Vol 94, Num 6, pp 1485-1495, issn 0002-9165, 11 p.Article
Resistance to antiretrovirals in HIV-infected pregnant womenWEINBERG, Adriana; FORSTER-HARWOOD, Jeri; VAZQUEZ, Anna et al.Journal of clinical virology. 2009, Vol 45, Num 1, pp 39-42, issn 1386-6532, 4 p.Article
Clonal CD8+ T cell expansions in peripheral blood from human immunodeficiency virus type 1-infected childrenMCFARLAND, Elizabeth J; HARDING, Paul A; STRIEBICH, Christopher C et al.The Journal of infectious diseases. 2002, Vol 186, Num 4, pp 477-485, issn 0022-1899, 9 p.Article
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccineMCFARLAND, Elizabeth J; BORKOWSKY, William; SINANGIL, Faruk et al.The Journal of infectious diseases. 2001, Vol 184, Num 10, pp 1331-1335, issn 0022-1899Article
Outbreak of Neurologic Enterovirus Type 71 Disease : A Diagnostic ChallengePEREZ-VELEZ, Carlos M; ANDERSON, Marsha S; ROBINSON, Christine C et al.Clinical infectious diseases. 2007, Vol 45, Num 8, pp 950-957, issn 1058-4838, 8 p.Article
Lymphocyte subsets in healthy children from birth through 18 years of age: The Pediatric AIDS Clinical Trials Group P1009 studySHEARER, William T; ROSENBLATT, Howard M; YOGEV, Ram et al.Journal of allergy and clinical immunology. 2003, Vol 112, Num 5, pp 973-980, issn 0091-6749, 8 p.Article
Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected womenCUNNINGHAM, Coleen K; WARA, Diane W; BORKOWSKY, William et al.Clinical infectious diseases. 2001, Vol 32, Num 5, pp 801-807, issn 1058-4838Article